With New Tax Savings, Drug Companies Start by Rewarding Shareholders, Not Patients Struggling with Skyrocketing Prices The Office of U.S. Senator Cory A. Booker, April 9, 2018 In December 2017, President Trump and the Republican-led Congress enacted the Tax Cuts and Jobs Act, a $1.5 trillion bill that delivers massive tax cuts to the nation’s…
via Drug companies using tax windfall to benefit shareholders, not patients — PNHP’s Official Blog
Advertisements
